The market for Diagnostics is an extensive market that is typically related to the Medtech market. It tends to include diagnostics in a stricter sense (Dx) which is related to screening and establishing if a patient has a condition or not.
Diagnostics in a wider sense also relate to prognostics assessing the probability of progression often related to therapy. The diagnostic market involves biomarkers identifying patient groups or other disease characteristics that allow a sufficient match between therapy and the specific patient.
Diagnostics can include research use only solutions, devices approved for clinical use and tests approved to be used together with specific therapies (companion diagnostics or Cx). The diagnostic market often includes hardware, disposable or consumable kits and sometimes advanced digital solutions.
The diagnostic market is increasingly important as the shift toward personalized medicine continues, and diagnostics is increasingly important to achieve a cost-efficient successful clinical outcome. It is especially important to look out for robust scientific support, health-economy support and the ability to attract larger strategic partners.
We have invited several interesting companies in the diagnostics field during this day that will present their businesses and their view on the market opportunities and challenges ahead.
Companies and schedules may change before the event starts.
You can save the date in your calendar by using Add to calendar.